
### [MONDO:0017979](http://purl.obolibrary.org/obo/MONDO_0017979)
**Label:** autoimmune lymphoproliferative syndrome

**Subclasses:** [MONDO:0011383](http://purl.obolibrary.org/obo/MONDO_0011383) (autoimmune lymphoproliferative syndrome type 2A), [MONDO:0011804](http://purl.obolibrary.org/obo/MONDO_0011804) (autoimmune lymphoproliferative syndrome type 2B), [MONDO:0014493](http://purl.obolibrary.org/obo/MONDO_0014493) (autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency), [MONDO:0014253](http://purl.obolibrary.org/obo/MONDO_0014253) (autoimmune lymphoproliferative syndrome type 3), [MONDO:0011158](http://purl.obolibrary.org/obo/MONDO_0011158) (autoimmune lymphoproliferative syndrome type 1), [MONDO:0013767](http://purl.obolibrary.org/obo/MONDO_0013767) (autoimmune lymphoproliferative syndrome type 4), 

**Corr. equiv. classes:** [OMIM:603909](http://purl.obolibrary.org/obo/OMIM_603909), [Orphanet:275517](http://www.orpha.net/ORDO/Orphanet_275517), [OMIM:607271](http://purl.obolibrary.org/obo/OMIM_607271), [Orphanet:268114](http://www.orpha.net/ORDO/Orphanet_268114), [OMIM:615559](http://purl.obolibrary.org/obo/OMIM_615559), [Orphanet:436159](http://www.orpha.net/ORDO/Orphanet_436159), [OMIM:616100](http://purl.obolibrary.org/obo/OMIM_616100), [OMIM:614470](http://purl.obolibrary.org/obo/OMIM_614470), [OMIM:601859](http://purl.obolibrary.org/obo/OMIM_601859), 

**Class expressions from DL-Learner:**

- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0031409](http://purl.obolibrary.org/obo/HP_0031409) (Abnormal lymphocyte physiology) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0030886](http://purl.obolibrary.org/obo/HP_0030886) (Abnormal lymphocyte apoptosis) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0011991](http://purl.obolibrary.org/obo/HP_0011991) (Abnormal neutrophil count) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0002960](http://purl.obolibrary.org/obo/HP_0002960) (Autoimmunity) 66.67%
- [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) and [HP:0002731](http://purl.obolibrary.org/obo/HP_0002731) (Decreased lymphocyte apoptosis) 66.67%
- [HP:0002240](http://purl.obolibrary.org/obo/HP_0002240) (Hepatomegaly) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0002012](http://purl.obolibrary.org/obo/HP_0002012) (Abnormality of the abdominal organs) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0001973](http://purl.obolibrary.org/obo/HP_0001973) (Autoimmune thrombocytopenia) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0001878](http://purl.obolibrary.org/obo/HP_0001878) (Hemolytic anemia) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0001875](http://purl.obolibrary.org/obo/HP_0001875) (Neutropenia) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0001874](http://purl.obolibrary.org/obo/HP_0001874) (Abnormality of neutrophils) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%
- [HP:0001873](http://purl.obolibrary.org/obo/HP_0001873) (Thrombocytopenia) and [HP:0002729](http://purl.obolibrary.org/obo/HP_0002729) (Follicular hyperplasia) 66.67%


